MENU
+Compare
CSTL
Stock ticker: NASDAQ
AS OF
Aug 11, 04:59 PM (EDT)
Price
$19.13
Change
-$0.23 (-1.19%)
Capitalization
561.6M

CSTL Castle Biosciences Forecast, Technical & Fundamental Analysis

Castle Biosciences Inc is a molecular diagnostics company... Show more

CSTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CSTL with price predictions
Aug 08, 2025

CSTL's RSI Indicator ascending out of oversold territory

The RSI Indicator for CSTL moved out of oversold territory on August 04, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 35 similar instances when the indicator left oversold territory. In of the 35 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 05, 2025. You may want to consider a long position or call options on CSTL as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CSTL just turned positive on August 05, 2025. Looking at past instances where CSTL's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

CSTL moved above its 50-day moving average on August 05, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for CSTL crossed bearishly below the 50-day moving average on July 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CSTL broke above its upper Bollinger Band on August 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CSTL entered a downward trend on August 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.233) is normal, around the industry mean (8.160). P/E Ratio (30.242) is within average values for comparable stocks, (132.856). CSTL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.738). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (1.642) is also within normal values, averaging (7.877).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CSTL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
CSTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CSTL is expected to report earnings to fall 548.00% to -67 cents per share on November 10

Castle Biosciences CSTL Stock Earnings Reports
Q3'25
Est.
$-0.67
Q2'25
Beat
by $0.66
Q1'25
Missed
by $0.14
Q4'24
Beat
by $0.31
Q3'24
Beat
by $0.08
The last earnings report on August 04 showed earnings per share of 15 cents, beating the estimate of -50 cents. With 119.87K shares outstanding, the current market capitalization sits at 561.60M.
A.I. Advisor
published General Information

General Information

is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients.

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
505 South Friendswood Drive
Phone
+1 866 788-9007
Employees
610
Web
https://www.castlebiosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPCX12.330.16
+1.31%
Saratoga Health & Biotechnology C
FSLEX44.330.16
+0.36%
Fidelity Environment & Alternative Engy
DSCGX29.110.05
+0.17%
DFA US Small Cap Growth Instl
VRSCX22.260.02
+0.09%
Voya SmallCap Opportunities Port R6
DEMZX25.81-0.22
-0.85%
Macquarie Emerging Markets R6

CSTL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with IMTH. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then IMTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSTL
1D Price
Change %
CSTL100%
-1.48%
IMTH - CSTL
41%
Loosely correlated
+0.07%
VCYT - CSTL
39%
Loosely correlated
-1.12%
NTRA - CSTL
38%
Loosely correlated
+7.70%
GH - CSTL
38%
Loosely correlated
+7.62%
TWST - CSTL
38%
Loosely correlated
+2.56%
More